Pages

Tirzepatide: A New Perspective on Obesity, Metabolism, and the Future of Treatment

Last Update: 2 August, 2026 | 20:31

Obesity is a chronic, progressive, relapsing disease — not a personal failure. This book examines tirzepatide and what a new generation of metabolic medicines means for treatment, prevention, and public health.

 

Tirzepatide: A New Perspective on Obesity, Metabolism, and the Future of Treatment

Obesity is not simply a number on a scale. Modern medicine treats it as a chronic, progressive, relapsing disease involving appetite, metabolism, and brain function — and a new generation of metabolic medicines has changed what treatment can offer. Prof. Seyed-Moayed Alavian examines tirzepatide, the science behind it, and what it means for individuals and for public health.

Cover of Tirzepatide: A New Perspective on Obesity, Metabolism, and the Future of Treatment by Dr. Seyed-Moayed Alavian

Publisher

Brieflands

Publication date

May 29, 2026

Print length

300 pages

Language

English

Format

Kindle edition

Subject

Obesity medicine and metabolic health

Audience

Patients, clinicians, and health policymakers

Get the book

Published by Brieflands and available worldwide as a Kindle edition on Amazon. For institutional orders, bulk copies, or translation rights, contact the publisher directly.

Buy on Amazon →Contact the publisher

Obesity — a matter beyond weight

At first glance obesity may look like an increase in body weight or BMI. In reality it is among the most complex health problems of the modern era, with roots that extend well beyond overeating or inactivity into biological, psychological, social, and economic territory.

The rising global prevalence of obesity over recent decades makes clear that it is not simply the product of individual choices. Lifestyle change, unhealthy food environments, chronic stress, sleep disorders, genetic and hormonal factors, and health policy itself all contribute to how obesity develops and persists. An oversimplified view does not just fail to help treatment — it produces social stigma, patient blame, and delayed intervention.

From the perspective of modern medicine, obesity is a chronic, progressive, and relapsing disease associated with dysregulation of appetite, metabolism, and brain function. It is directly linked to increased risk of type 2 diabetes, cardiovascular disease, fatty liver, certain cancers, and mental health disorders, and it materially affects quality of life.

Only with such a perspective can an effective treatment path be designed, where obesity is not viewed as a personal failure, but as a manageable challenge at both the individual and societal levels.Prof. Seyed-Moayed Alavian — from the opening chapter

What the book covers

A scientific, humane, and sustainable approach to treatment.

Obesity as a disease

Why modern medicine classifies obesity as chronic and relapsing, and what follows from that framing.

The metabolic mechanism

How appetite, metabolism, and brain signalling interact — the biology these medicines act on.

Tirzepatide in context

Where this treatment sits among the options available, and what the clinical evidence describes.

Associated conditions

The links to type 2 diabetes, cardiovascular disease, fatty liver, cancer risk, and mental health.

Beyond blame

Why stigma delays effective care, and what a non-judgemental clinical approach looks like.

A societal view

Food environments, health policy, and treatment access as part of the same problem.

Important. Tirzepatide is a prescription medicine. This book is educational and does not recommend, prescribe, or provide dosing guidance for any treatment. Decisions about starting, changing, or stopping any obesity or diabetes medication must be made with a qualified clinician who can assess your history, other medications, and possible adverse effects. Never obtain prescription medicines from unregulated sources.